-
Taking a Short Break
We’re taking a two-day break at Science and Enterprise, to conduct some personal business.
-
Esophagus Tissue from Stem Cells Grown, Implanted
Replacement engineered esophagus tissue grown from stem cells was shown in tests with pigs to be a feasible alternative to transplanting pieces from other parts of the body for people with esophagus cancer.
-
Cancer Drug Seen to Reverse Autism Spectrum Symptoms
Small doses of a drug for blood-related cancers are shown in lab mice to reverse social symptoms often found in children with autism spectrum disorder, a condition characterized by limited social activity.
-
Boron Radiation Therapy Company Forms with $40M Funding
A start-up enterprise, spun off from a fusion energy company, plans to develop radiation therapies for solid tumor cancers often considered difficult to treat with conventional methods.
-
Turning Your Small Product into a Big Business
Now that it’s easier than ever to start up online, there’s nothing to stop you turning your small product, or a small idea, into a big business.
-
Trial Shows Patch Feasible for Heart Rhythm Detection
Results from a clinical trial show a wearable patch, applied and used by older adults in their homes, detects more heart rhythm problems than waiting to see a doctor, the usual way these problems are detected.
-
Infographic – How Tech Companies Make Money
Our friends at Statista provide this chart that offers insights into the business models of the top tech companies.
-
Smartphone App, Device Shown to Measure Blood Pressure
A smartphone-based system and app were shown in a pilot study with human subjects to measure a person’s blood pressure with about the same accuracy as some cuff devices normally used to gauge blood pressure.
-
What Exactly Is Pharmaceutical Market Access?
Market access is a process which is out in place to ensure that any patient who is appropriate for receiving a certain medicine is able to receive it at a decent price.
-
A.I. Shown to Boost Cancer Clinical Trial Enrollment
Early results from a system using a supercomputer and artificial intelligence to match breast cancer patients to clinical trials shows faster screening and higher enrollment rates in these studies compared to manual methods.